Evidence map›Paper›PMID 27704009›Full record

ArticleOpen forum infectious diseases2016

Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009.

Amy E Blain, Sema Mandal, Henry Wu, Jessica R MacNeil, Lee H Harrison, Monica M Farley, Ruth Lynfield, Lisa Miller, Megin Nichols, Sue Petit and 9 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Progression of antibiotic resistance inClinical microbiology reviews · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 1 country.

Amy E BlainDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases , Centers for Disease Control and Prevention , Atlanta, Georgia.
Sema MandalDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases , Centers for Disease Control and Prevention , Atlanta, Georgia.
Henry WuDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases , Centers for Disease Control and Prevention , Atlanta, Georgia.
Jessica R MacNeilDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases , Centers for Disease Control and Prevention , Atlanta, Georgia.
Lee H HarrisonDepartment of International Health , Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland.
Monica M FarleyDepartment of Medicine , Emory University School of Medicine and the Atlanta VA Medical Center , Georgia.
Ruth LynfieldMinnesota Department of Health, St. Paul.
Lisa MillerColorado Department of Public Health and Environment, Denver.
Megin NicholsNew Mexico Department of Health, Sante Fe.
Sue PetitConnecticut Department of Public Health, Hartford.
Arthur ReingoldSchool of Public Health , University of California , Berkley.
William SchaffnerDepartment of Preventive Medicine , Vanderbilt University School of Medicine , Nashville, Tennessee.
Ann ThomasOregon Department of Human Services, Portland.
Shelley M ZanskyNew York State Department of Health, Albany.
Raydel AndersonDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases , Centers for Disease Control and Prevention , Atlanta, Georgia.
Brian H HarcourtDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases , Centers for Disease Control and Prevention , Atlanta, Georgia.
Leonard W MayerDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases , Centers for Disease Control and Prevention , Atlanta, Georgia.
Thomas A ClarkDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases , Centers for Disease Control and Prevention , Atlanta, Georgia.
Amanda C CohnDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases , Centers for Disease Control and Prevention , Atlanta, Georgia.
National Center for Immunization and Respiratory Diseases · USCenters for Disease Control and Prevention · USAtlanta VA Medical Center · USColorado Department of Public Health and Environment · USConnecticut Department of Public Health · USJohns Hopkins University · USMinnesota Department of Health · USNew Mexico Department of Health · USNew York State Department of Health · USOregon Department of Human Services · USVanderbilt University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2009, in the Active Bacterial Core surveillance sites, penicillin was not commonly used to treat meningococcal disease. This is likely because of inconsistent availability of antimicrobial susceptibility testing and ease of use of third-generation cephalosporins. Consideration of current practices may inform future meningococcal disease management guidelines.

Indexed as

antimicrobial resistancemeningitismeningococcal diseaseNeisseria meningitidis

Identifiers

PMID27704009
PMCPMC5047430
OpenAlexW2466900457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.